The chain’s situation shows the complicated legal and reputational landscape that it and its competitors must navigate in the post-Roe era.
Category: Drugs (Pharmaceuticals)
-
Walgreens Faces Blowback for Not Offering Abortion Pill in 21 States
The New York Times – Business: -
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative States
The New York Times – Business:The decision applies to 21 states whose attorneys general threatened Walgreens and other pharmacies with legal action if they dispensed the pill there.
-
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addiction
The New York Times – Business:The case illustrates the enormous challenges that victims of the opioid crisis have had in getting compensation from the pharmaceutical industry, despite its pledge of billions of dollars to state and local governments.
-
Eli Lilly Says It Will Cut the Price of Insulin
The New York Times – Business:The company said it would cap the monthly out-of-pocket cost of the diabetes drug at $35.
-
A Drug Company Exploited a Safety Requirement to Make Money
The New York Times – Business:With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.
-
12 States Sue F.D.A., Seeking Removal of Special Restrictions on Abortion Pill
The New York Times – Business:The suit argues that rules applying to mifepristone unnecessarily limit patients’ access to medication abortion.
-
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Conclude
The New York Times – Business:The overdose reversal drug has been administered mostly by emergency responders and outreach workers. If the agency approves a nonprescription version, it could become as easily available as aspirin.
-
Bernie Sanders Has a New Role. It Could Be His Final Act in Washington.
The New York Times – Business:After two unsuccessful runs for the presidency, the Vermont senator now leads the Senate health committee, a job that gives him sweeping jurisdiction over issues he cares about.
-
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
The New York Times – Business:Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
-
The Medicine Is a Miracle, but Only if You Can Afford It
The New York Times – Business:A wave of new treatments have cured devastating diseases. When the costs are too much, even for the insured, patients hunt for other ways to pay.
-
GoodRx Leaked User Health Data to Facebook and Google, F.T.C. Says
The New York Times – Business:The popular drug discount app deceptively shared details on users’ illnesses and medicines with ad firms, regulators said in a legal complaint.